Biomica
Agent37Agent Readiness: 37/100. Below median. Measured by StartupHub.ai. Median 41.Trust69Data Trust: 69/100. Above median. Measured by StartupHub.ai. Median 61.Biomica is developing a novel microbiome-based platform for the treatment of cancer.
About
Biomica is a clinical-stage biopharmaceutical company focused on developing microbiome-based therapeutics for cancer. Their platform leverages a deep understanding of the microbiome's role in cancer and its response to immunotherapy to create novel drug candidates. They aim to address unmet needs in oncology by offering new treatment options.
Similar companies
Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Shares Life Sciences, Biotech
AI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Shares Life Sciences, Clinical Trials
AI-powered blood test for early cancer detection and subtyping.
Shares Life Sciences, Biotech
Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.
Shares Life Sciences, HealthTech
Omnix Medical is developing a novel platform for advanced wound care management.
Shares Life Sciences, HealthTech
Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.
Shares Life Sciences, Biotech
Key facts
At-a-glance profile data
- Website
- biomicamed.com
- Headquarters
- Rehovot, Israel
- Founded
- 2018
- Employees
- 7
- Total funding
- -
- Business model
- B2B
Tech stack
Detected on biomicamed.com, last scanned 11 Oct 2026. Run your own scan
- Frontend
- jQuery
- Email provider
- Microsoft 365
Frequently asked
Is Biomica trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Biomica is 69 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How many employees does Biomica have?
Biomica has approximately 7 people on record.
